Brief report: Combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts

Stem Cells

Volumn 29, Issue 3, 2011, Pages 549-553

  Yuan, Xu ^a   Wan, Haifeng ^b,c   Zhao, Xiaoyang ^b,c   Zhu, Saiyong ^a   Zhou, Qi ^b   Ding, Sheng ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b INSTITUTE OF ZOOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

iPSC; Pluripotent stem cells; Reprogramming; TGF

Indexed keywords

A 83 01; AMI 5; METHYLTRANSFERASE INHIBITOR; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PROTEIN METHYLATION; TETRAPLOIDY;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; DRUG COMBINATIONS; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; INDUCED PLURIPOTENT STEM CELLS; METHYLTRANSFERASES; MICE; MODELS, BIOLOGICAL; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; PYRAZOLES; THIOCARBAMATES; TRANSFORMING GROWTH FACTOR BETA;

MAMMALIA;

EID: 79953001876     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.594     Document Type: Article

References (29)

1. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
2. Lowry WE, Richter L, Yachechko R et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 2008;105:2883-2888. (Pubitemid 351723638)
3. Aoi T, Yae K, Nakagawa M et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008;321:699-702.
4. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451:141-146.
5. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
6. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872. (Pubitemid 350138099)
7. Wernig M, Meissner A, Foreman R et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448:318-324.
8. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317. (Pubitemid 47080336)
9. Kim JB, Zaehres H, Wu G et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008;454:646-650.
10. Huangfu D, Osafune K, Maehr R et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008;26:1269-1275.
11. Shi Y, Do JT, Desponts C et al. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008;2:525-528. (Pubitemid 351729222)
12. Li W, Zhou H, Abujarour R et al. Generation of human induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 2009;27:2992-3000.
13. Shi Y, Desponts C, Do JT et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 2008;3:568-574.
14. Kim JB, Greber B, Arauzo-Bravo MJ et al. Direct reprogramming of human neural stem cells by OCT4. Nature 2009;461:649-643.
15. Kim JB, Sebastiano V, Wu G et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009;136:411-419.
16. Li Y, Zhang Q, Yin X et al. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res 2011;21:196-204.
17. Wernig M, Meissner A, Cassady JP et al. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008;2:10-12.
18. Nakagawa M, Koyanagi M, Tanabe K et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008;26:101-106.
19. Huangfu D, Maehr R, Guo W et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008;26:795-797. (Pubitemid 351961456)
20. Ichida JK, Blanchard J, Lam K et al. A small-molecule inhibitor of Tgf-beta signaling replaces Sox2 in reprogramming by inducing Nanog. Cell Stem Cell 2009;5:491-503.
21. Maherali N, Hochedlinger K. Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr Biol 2009;19:1718-1723.
22. Lin T, Ambasudhan R, Yuan X et al. A chemical platform for improved induction of human iPSCs. Nat Methods 2009;6:805-808.
23. Mali P, Chou BK, Yen J et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 2010;28:713-720.
24. Cheng D, Yadav N, King RW et al. Small molecule regulators of protein arginine methyltransferases. J Biol Chem 2004;279:23892-23899. (Pubitemid 38725246)
25. Boland MJ, Hazen JL, Nazor KL et al. Adult mice generated from induced pluripotent stem cells. Nature 2009;461:91-94.
26. Zhao XY, Li W, Lv Z et al. iPS cells produce viable mice through tetraploid complementation. Nature 2009;461:86-90.
27. Bedford MT, Richard S. Arginine methylation an emerging regulator of protein function. Mol Cell 2005;18:263-272. (Pubitemid 41350532)
28. Pal S, Sif S. Interplay between chromatin remodelers and protein arginine methyltransferases. J Cell Physiol 2007;213:306-315. (Pubitemid 47509707)
29. Wolf SS. The protein arginine methyltransferase family: An update about function, new perspectives and the physiological role in humans. Cell Mol Life Sci 2009;66:2109-2121.